• 제목/요약/키워드: Hospital death

검색결과 1,937건 처리시간 0.036초

말티즈견에서 발생한 Mitral Valve Endocardiosis (MVE)를 동반한 Sick Sinus Syndrome (SSS)에 대한 증례 (Sick Sinus Syndrome (SSS) in a Maltese Dog Concurrent with Mitral Valve Endocardiosis (MVE))

  • 박철;정동인;김하정;강병택;김주원;임채영;유종현;박희명
    • 한국임상수의학회지
    • /
    • 제22권4호
    • /
    • pp.396-400
    • /
    • 2005
  • 13년령의 암컷 말티즈견이 5개월간의 일시적인 기절현상 (syncope)을 주증상으로 내원하였다. 환축은 병력 청취 신체검사 심장검사 총혈액검사, 혈액 화학적 검사, 방사선학적 검사, 심전도 검사, 아트로핀 반응 검사 (atropine response test), 호르몬 검사, 심전도 검사 등을 통해 심장의 문제가 있는 것으로 진단되었다. 본 증례에서 심전도 검사는 아트로핀 투여에 의한 심전도 기록을 통해 sick sinus syndrome을 확진 하는데 중요한 역할을 하였다. 임상 증상은 테오필린 (THEOLANi, 근화제약, 서울, 한국, 20mg/kg, 경구 투여, 1일 2회)을 복용하면서 개선되었다. 환축은 10개월을 생존하였으나 지역 병원에서 복강의 종괴를 제거하는 수술을 받는 중 호흡곤란과 쇼크로 사망하였다. 사망 후 보호자의 반대로 부검은 이루어지지 않았다.

이차공형 심방중격결손증의 외과적 치료;연령에 따른 혈류학적 상관관계에 관한 고찰 (Surgical Repair of Isolated Secundum Atrial Septal Defect - Clinical features, hemodynamic function, early and late results according to age at operation -)

  • 이섭;최병철;안욱수;허용;김병열;이정호;유회성
    • Journal of Chest Surgery
    • /
    • 제25권11호
    • /
    • pp.1318-1326
    • /
    • 1992
  • Backgroud. To determine the influence of age at operation upon surgical outcome in patients with isolated secundum atrial septal defect, retrospective clinical analysis was done. Material and method. From June, 1976 to December, 1991, 146 patients, 63 male and 83 female patients ranging in age from 13 months to 56 years, were operated on for isolated secundum atrial septal defect. The patients were divided into 3 groups according to their age at operation: Group I [<20 years old], 91 patients[62.3%]; Group II [21 to 40 years old], 44 patients[30.1%]; GroupIII[>41 years old], 11 patients[7.6%]. Significant differences in clinical features, hemodynamic function, early and late results between age groups were speculated. Results. One hundred thirty-one patients[89.6%] were symptomatic at the time of operation, the most common symptoms being dyspnea on exertion, recurrent respiratory infection, palpitation and chest pain. Patients in NYHA class III or IV were 3.3% in group I, 25% in groupIII, and 54.5% in group Ill. Hemodynamic data was available for 138 patients [94.5%]. Significant pulmonary hypertension [MPA systolic pressure $^3$ 40mmHg] was noted in 22 patients [15.9%]. Patients with pulmonary vascular disease [Rp/Rs>1.25] were 2% in group I, 7.3% in group Il, and 9.1% in groupIII. But there were no significant differences between the age groups in the size of the shunt or the ratio of pulmonary to systemic flow. Atrial septal defects were closed with direct suture in 144 patients and patch repair was performed in 2 patients with high defect. Atrial arrhythmia [8.2%] was the most common postoperative complication. The mean [LSD] duration of follow-up in all patients was 16$\pm$22 months [range, 1~96 months]. Functional result was excellent regardless of the age groups. During follow-up period, late cardiovascular events were arrhythmia [7 cases], reoperation for recurrent ASD [2 cases], and premature late death due to bacterial endocarditis [1 case]. Incidence of preoperative and late atrial fibrillation was significantly higher in older age group. Conclusion. Age at operation is one of the most important predictor of early and late surgical outcome with its impact on the following factors : 1] hemodynamic alterations and ventricular dysfunction due to longstanding volume and pressure overload, 2] pulmonary vascular disease, and 3] atrial arrhythmia including atrial fibrillation as a result of atrial dilatation. Therefore, among patients with surgically repaired atrial septal defects, those operated on over the age of 20 require careful supervision on the long-term basis.

  • PDF

Duromedics 판막의 장기 임상 성적 고찰 (Long Term Clinical Results of Duromedics Valve)

  • 정동섭;임청;김경환;김기봉;안혁
    • Journal of Chest Surgery
    • /
    • 제34권9호
    • /
    • pp.686-691
    • /
    • 2001
  • 배경: Duromedics 판막은 1982년부터 사용되어 왔으나 국내에서는 장기 임상 성적에 대한 보고가 없는 실정이다. 이에 본원에서 시행된 Duromedics 판막의 장기 임상 성적을 보고하는 바이다. 대상 및 방법: 1987년부터 1988년 사이에 23명의 성인 환자에게 Duromedics 기계판막을 이용하여 판막치환술을 시행하였다. 승모판막 치환이 8예, 대동맥판 치환이 5예, 삼첨판막 치환이 1예, 대동맥판막과 승모판막을 동시에 치환한 경우가 6예, 승모판막과 삼첨판막을 동시에 치환한 경우가 1예였다. 남자 환자가 12명, 여자 환자가 11명이었고 환자들의 평균 연령은 35$\pm$10(15~52) 세였다. 저자들은 이 환자들에게 치환된 Duromedics 기계 판막의 임상적인 결과를 추적 조사하였다. 결과: 조기 사망은 1예로서 4.3%(1/23)의 조기 사망률을 보였고 만기 사망도 1예로서 4.3%(1/23)의 만기 사망률을 보였다. 사망 원인은 저심박출 증후군과 구조적 판막실패였다. 평균 추적기간은 133$\pm$43개월(8~157)이었다. 재수술을 시행한 경우는 모두 3예가 있었는데 판막혈전증이 1예, 구조적 판막이상이 1예, 비구조적 판막 이상이 1예였다. 10년 생존율(actuarial survival rate)은 90.9%이었다. 결론: 비록 임상 연구를 하기에 충분한 환자 수는 아니었지만, Duromedics 판막의 장기 임상 성적은 다른 판막에 비해 우수하거나 비슷하였으며, 구조적 결함도 발견되지 않았다. 하지만 향후 좀더 연구가 이루어져야 할 것으로 생각된다.

  • PDF

하지동맥 폐쇄성 질환에서 자가 대복재정맥 정위 이식편의 이용 (The Use of Greater Saphenous Vein In Situ Graft in Arterial Occlusive Disease of Lower Extremity)

  • 신용철;김미정;송창민;안재범;김인섭;김우식;김병열
    • Journal of Chest Surgery
    • /
    • 제39권6호
    • /
    • pp.456-461
    • /
    • 2006
  • 배경: 하지동맥의 협착성 질환에서 슬와동맥 및 그 이하 분지들의 협착이 있을 경우 인조혈관과 슬와 동맥 사이의 크기 불일치가 발생하여 원위부 문합이 곤란하게 된다. 본원에서는 자가 대복재정맥 정위 이식편을 이용하여 하지동맥의 혈류를 복원하고자 하였다. 대상 및 방법: 2000년 7월부터 2005년 7월까지 총 26명의 환자에서 대복재정맥 정위 이식편을 이용한 수술을 시행하였으며, 임상 결과들을 환자의 차트 기록에 근거하여 후향적으로 분석하였다. 결과: 술 후 원내 사망이나 조기 사망은 없었으며, 추적기간 동안 총 6명의 만기 사망이 발생하였다. 수술 도중 및 술 후 합병증으로는 5예의 조기 이식편 폐쇄, 2예의 창상 열개, 1예의 이식편 내 동맥류 형성, 1예의 서혜부 창상 장액종 형성, 1예의 이식편 손상이 발생하였으며, 추적기간 동안 이식편 개통률은 69.3%였다. 결론: 대복재정맥 정위 이식편은 슬와동맥 및 그 이하 분지의 협착을 동반한 하지동맥 폐쇄성 질환에서 유용한 혈관 이식편으로 생각된다.

신종 플루 폐렴으로 입원한 환자들에서 주요 합병증 발생과 관련된 인자 (Associated Factor Related to Major Complications of Patients with Hospitalized for 2009 H1N1 Influenza Pneumonia)

  • 최상식;김원영;김성한;홍상범;임채만;고윤석;김원;임경수
    • Tuberculosis and Respiratory Diseases
    • /
    • 제68권3호
    • /
    • pp.162-167
    • /
    • 2010
  • Background: To date, there are few data on the risk factors for severe cases and deaths associated with the 2009 pandemic H1N1 influenza A. Here, we describe the clinical and epidemiologic characteristics of patients hospitalized for pneumonia and identify those factors associated with the development of major complications (MC). Methods: We reviewed the medical records of 41 cases of pneumonia admitted to a university-affiliated tertiary hospital between Aug 26 and Dec 10, 2009, and who had confirmed H1N1 influenza A based on real-time reverse transcriptase-polymerase-chain-reaction assay. There were 7,962 patients that fit these criteria. We compared the clinical features and demographic characteristics of patients who developed MC to with those who did not develop MC. Results: During the study period, 10 patients developed MC (required admission to the intensive care unit, n=10; required ventilator therapy, n=6; death, n=4). Patients with MC were significantly older than those without MC and more frequently had underlying medical conditions (90.0% vs 41.9%, p-value <0.01). In the patients with developed MC, the median $PaO_2/FiO_2$ ratio of 230.0 (145.0~347.3) at admission and pneumonia severity index (PSI) score of 141.5 (88.3~158.5) were higher than patients without MC. However, no differences were observed in laboratory findings or in viral shedding between the 2 groups. Conclusion: In hospitalized pneumonia patients of 2009 H1N1 influenza, old age, a history of malignancy, initial hypoxemia, $PaO_2/FiO_2$ ratio, and PSI score appear to be risk factor significantly related to developing MC. These findings might be the basis to influence strategies for admitting patients to an intensive or intermediate care unit and for pre-emptive antiviral therapy.

관상동맥 스텐트 삽입술 후 Clopidogrel과 Cilostazol의 비교 (Comparison of Clopidogrel versus Cilostazol in Coronary Artery Stenting)

  • 송인숙;최승기;오정미
    • 한국임상약학회지
    • /
    • 제15권2호
    • /
    • pp.105-117
    • /
    • 2005
  • Following intracoronary stenting, antiplatelet therapy lead to greater protection from thrombotic complication. A few data are available about the effect of clopidogrel versus cilostazol, an antiplatelet commonly used after intracoronary stenting. To evaluate the efficacy and safety of clopidogrel plus aspirin compared with those of cilostazol plus aspirin in coronary stenting and to evaluate the efficacy of clopidogrel loading dose prior to coronary stealing in clopidogrel group. Data were retrospectively collected from medical charts of patients who had undergone coronary stenting and received either clopidogrel with or without loading 300 mg followed by 75 mg/d (n=58), or 200 mg/d cilostazol(n=72) for 1 year, between January 2000 and May 2002. All patients in both groups received aspirin 200 mg/d throughout the study. The primary endpoints at 7, 30, 180 and 365 days after stealing were the composite of death, Myocardial Infarction, stroke, angina, and revascularization in the intent to treat population and restenosis at follow up angiography. The secondary endpoints were the incidence of bleeding complications at 7, 30, and 365 days, and durg adverse effects at 365 days after stenting. At 180 and 365 days after stenting, the combined primary endpoints were significantly reduced in clopidogrel plus aspirin group (relative risk 0.39; 95% CI 0.17 to 0.92; p=0.021, RR 0.43; 95% CI 0.22 to 0.84; p=0.0085, respectively). However, the combined primary endpoints were not significantly different between the two groups at 7 and 30 days (p:1.00, p=0.79, respectively). Angiographic restenosis rate was 14.3% in clopidogrel plus aspirin uoup and 32.1% in cilostazol plus aspirin group (p=0.19). 300mg of clopidogrel loading dose did not significantly reduce the combined primary endpoints at 30 days after stenting (RR 0.14; 95% CI 0.01 to 2.65; p=0.23). The rate of bleeding complications and drug adverse effects were not different between the two groups. In patients undergoing intracoronary stenting, clopidogrel plus aspirin therapy is more beneficial than cilostazol plus aspirin in reducing major adverse cardiac events with similar rate of bleeding complication. A loading dose of clopidogrel did not lead to a statistically significant reduction in major adverse cardiac events.

  • PDF

항암 치료를 받은 아동의 치아 발육 장애 (DEVELOPMENTAL DENTAL COMPLICATIONS AFTER ANTICANCER THERAPY IN CHILDREN)

  • 김민정;이형숙;김신;정태성
    • 대한소아치과학회지
    • /
    • 제36권4호
    • /
    • pp.607-612
    • /
    • 2009
  • 소아기의 악성 종양은 질병으로 인한 소아 사망의 가장 흔한 원인이다. 이에 대한 대표적인 치료 방법으로 항암 화학 요법과 방사선 요법의 단독 사용 혹은 이들의 병용을 들 수 있다. 그러나 이러한 치료 방법은 다양한 구강 내 합병증을 동반한다. 성인과 달리 소아 환자는 항암치료 시기에 일부 영구치가 활발한 발육단계에 있으므로 발육중인 치아에 치과적 합병증이 예상된다. 치과적 합병증의 정도는 화학약물의 종류, 용량 및 방사선 조사 빈도와 치료 당시 환자의 나이에 따라 달라진다. 본 증례들에서는 특정 영구치의 발육단계에 있는 만 1-4세경에 종양의 치료를 위해 항암 화학 요법과 방사선 치료를 받은 어린이 3명을 대상으로 치료 내용과 치아 발육 상황을 검토해 보았다. 이환된 치아의 수나 그 정도에 차이는 있으나, 각각의 환자에서 영구치 치배의 선천 결손, 왜소치, 치근 저형성 등 발육장애 관련 소견이 관찰되었다. 항암치료를 받은 병력이 있는 소아에 있어서 항암치료 이후에 나타날 수 있는 일반적인 구강 합병증 이외에 발육시기 동안 치아에 미치는 영향을 고려하여, 공간 문제를 포함하여 향후 발생 할 수 있는 다앙한 문제점 예방을 위한 장기적인 관찰과 관리가 필요할 것으로 생각된다.

  • PDF

Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms

  • Duangnapasatit, Boonlerd;Rattarittamrong, Ekarat;Rattanathammethee, Thanawat;Hantrakool, Sasinee;Chai-Adisaksopha, Chatree;Tantiworawit, Adisak;Norasetthada, Lalita
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권12호
    • /
    • pp.5013-5018
    • /
    • 2015
  • Background: Myeloproliferative neoplasms (MPNs) are clonal hematopoietic stem cell disorders characterized by proliferation of one or more myeloid lineages. Polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF) are classical Philadelphia chromosome (Ph)-negative MPN that have a Janus Kinase 2 (JAK2) mutation, especially JAK2V617F in the majority of patients. The major complications of Ph-negative MPNs are thrombosis, hemorrhage, and leukemic transformation. Objective: To study clinical manifestations including symptoms, signs, laboratory findings, and JAK2V617F mutations of Ph-negative MPN (PV, ET and PMF) as well as their complications. Materials and Methods: All Ph-negative MPN (PV, ET and PMF) patients who attended the Hematology Clinic at Maharaj Nakorn Chiang Mai Hospital from January, 1 2003 through December, 31 2013 were retrospectively reviewed for demographic data, clinical characteristics, complete blood count, JAK2V617F mutation analysis, treatment, and complications. Results: One hundred and fifty seven patients were included in the study. They were classified as PV, ET and PMF for 68, 83 and 6 with median ages of 60, 61, and 68 years, respectively. JAK2V617F mutations were detected in 88%, 69%, and 100% of PV, ET and PMF patients. PV had the highest incidence of thrombosis (PV 29%, ET 14%, and PMF 0%) that occurred in both arterial and venous sites whereas PMF had the highest incidence of bleeding (PMF 17%, ET 11%, and PV 7%). During follow up, there was one ET patient that transformed to acute leukemia and five cases that developed thrombosis (three ET and two PV patients). No secondary myelofibrosis and death cases were encountered. Conclusions: Ph-negative MPNs have various clinical manifestations. JAK2V617F mutations are present in the majority of PV, ET, and PMF patients. This study confirmed that thrombosis and bleeding are the most significant complications in patients with Ph-negative MPN.

Prostate Cancer Screening in a Healthy Population Cohort in Eastern Nepal: an Explanatory Trial Study

  • Belbase, Narayan Prasad;Agrawal, Chandra Shekhar;Pokharel, Paras Kumar;Agrawal, Sudha;Lamsal, Madhab;Shakya, Vikal Chandra
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권5호
    • /
    • pp.2835-2838
    • /
    • 2013
  • Background: Prostate cancer features a substantial incidence and mortality burden, similarly to breast cancer, and it ranks among the top ten specific causes of death in males. Objective: To explore the situation of prostate cancer in a healthy population cohort in Eastern Nepal. Materials and Methods: This study was conducted in the Department of General Surgery at B. P. Koirala Institute of Health Sciences, Dharan, Nepal from July 2010 to June 2011. Males above 50 years visiting the Surgical Outpatient Department in BPKIHS were enrolled in the study and screening camps were organized in four Teaching District Hospitals of BPKIHS, all in Eastern Nepal. Digital rectal examination (DRE) was conducted by trained professionals after collecting blood for assessment of serum prostatic specific antigen (PSA). Trucut biopsies were performed for all individuals with abnormal PSA/DRE findings. Results: A total of 1,521 males more than 50 years of age were assessed and screened after meeting the inclusion criteria. The vast majority of individuals, 1,452 (96.2%), had PSA ${\leq}4.0$ ng/ml. Abnormal PSA (>4 ng/ml) was found in 58 (3.8%). Abnormal DRE was found in 26 (1.72%). DRE and PSA were both abnormal in 26 (1.72%) individuals. On the basis of raised PSA or abnormal DRE 58 (3.84%) individuals were subjected to digitally guided trucut biopsy. Biopsy report revealed benign prostatic hyperplasia in 47 (3.11%) and adenocarcinoma prostate in 11 (0.73%). The specificity of DRE was 66.0%with a sensitivity of 90.9% and a positive predictive value of 38.5%. The sensitivity of PSA more than 4ng/ml in detecting carcinoma prostate was 100% and the positive predictive value for serum PSA was 19.0% Conclusions: The overall cancer detection rate in this study was 0.73% and those detected were locally advanced. Larger community-based studies are highly warranted specially among high-risk groups.

Urokinase와 동의학적요법(東醫學的療法)으로 동시치료(同時治療)한 허혈성뇌졸중환자(虛血性腦卒中患者) 56례(例)에 대(對)한 임상적(臨床的) 연구(硏究) (Clinical Studies on 56 Cases of Having Treated patients suffering from Ischemic Stroke through both Urokinase and Therapeutics of Oriental Medicine)

  • 김인섭
    • 대한한의학회지
    • /
    • 제15권2호
    • /
    • pp.46-91
    • /
    • 1994
  • l. Backgrounds of Studies Cerebrovascular accident. one of the three major causes of death among audults with cardiopathy and malignancy, has been on the increase in korea while it is on the decrease in European countries and Japan. Types of stroke undergo changes caused by prolongment of life expectancy. and social and economic variety. More patients of ischemic stroke show a tendency to increase now than those of hemorrhagic stroke in the past. Many clinical studies on medical cerebrovascular and oriental stroke of paralysis have been published. but few clinical studies on therapeutics of integrated oriental and western medicine are to be found. So I have made an attempt to study clinical observations and therapeutic responses of ischemic stroke under integrated oriental and western medicine. 2.Methods. Among the patients admitted into the clinic of Joong-Poong, Woo-Suk University Hospital from May 1. 1993 until April 30. 1994 those 56 patients who were diagnosed as ischemic stroke on Computed Tomography(CT) and showed no dubious symptom after examination of coagulation and bleeding time were classified into the following six steps and treated: l)diagnosis 2)emergency treatment 3)basic treatment 4)treatment of risk and provoking factors. and preceeding disease 5)complications and conservative therapy 6)rehabilitation. For a period of basic treatment both herb medication and urokinase therapy were applied at the same time. Intravenous injection has been given at a unit of 300.000 dosage a day as urokinase therapy during basic treatment. If they showed any dubious symptom in glucose tolerance test. fructose 500ml and urokinase 300.000 dosage were mixed and injected. In case of no symptom 5% DW 500ml was mixed with urokinase 300.000 unit. and injected at a speed of 15gtt per minute. 3. Results and Conclusions 1) The level of ambulation has been improved from 42.9% when admitted to 73.2% when discharged in the degree of recovery. The level of severe function disorder has been remarkably decreased from 55.4% when admitted to 19.6% when discharged. 2) The treatment effect on the basis of therapeutic response of clinical and subjective symptom shows as follows: 7.1% Excellent. 35.7% Good. 37.5% Effective. 10.7% Stationary. and 8.9% Aggravated. The total recovery above effective shows 80.3%. Judging from the above results I think it proper to develop the model of better preventing and treating ischemic stroke through effective therapeutic and clinical studies of integrated oriental and western medicine.

  • PDF